Spread & Containment
Amazon debuts a fully autonomous warehouse robot
You can’t discuss fulfillment robots without mentioning Amazon. Over the past decade, the retail juggernaut has become the 800-pound gorilla in the category,…

You can’t discuss fulfillment robots without mentioning Amazon. Over the past decade, the retail juggernaut has become the 800-pound gorilla in the category, courtesy of several key acquisitions and seemingly endless resources. And while warehouse robotics and automation have been accelerated amid the pandemic and resulting employment crunch, Amazon Robotics has been driving these categories for years now.
This week at its annual Re:Mars conference in Las Vegas, the company celebrated a decade of its robotics division, which was effectively born with its acquisition of Kiva Systems. Over the course of its life, Amazon Robotics has deployed more than 520,000 robotic drive units, across its fulfillment and sort centers. From the outside, it’s been a tremendous success in the company’s push toward same- and next-day package delivery, and its driven the competition to look for their own third-party robotics solutions, bolstering startups like Locus, Fetch and Berkshire Grey.
Amazon Robotics head Tye Brady took to the stage at today’s event to offer a glimpse at what the future will look like for its in-house automated systems. At the heart of the news are two new robots: Proteus and Cardinal, an autonomous floor system and a robotic arm, respectively. The new robots are being integrated into the same shelf/cell system that’s been in place since Kiva.
Now, however, Proteus brings full autonomy to the floor. The company notes in a blog post,
Proteus autonomously moves through our facilities using advanced safety, perception, and navigation technology developed by Amazon. The robot was built to be automatically directed to perform its work and move around employees—meaning it has no need to be confined to restricted areas. It can operate in a manner that augments simple, safe interaction between technology and people—opening up a broader range of possible uses to help our employees—such as the lifting and movement of GoCarts, the non-automated, wheeled transports used to move packages through our facilities.
If I had to venture an educated guess, I’d say that Proteus is likely the result of the company’s 2019 acquisition of Boulder, Colorado-based autonomous cart company, Canvas. As I noted at the time, “Canvas […] brings its own built-in safety with its autonomous vision system. The hardware is designed to more directly interact with workers on the floor. It’s easier to imagine the company adopting the technology for some of its existing systems, as well.”
Image Credits: Amazon
From the looks of it, some of that Canvas technology was integrated into a Kiva form factor, so these robots can work with Amazon’s existing systems, with minimal retrofitting. What the additional autonomy brings is the ability to operate in less controlled environments, which means the technology can be implemented into additional environments outside of the current cages that the Kiva systems are relegated to.
The company notes,
Proteus will initially be deployed in the outbound GoCart handling areas in our fulfillment centers and sort centers. Our vision is to automate GoCart handling throughout the network, which will help reduce the need for people to manually move heavy objects through our facility and instead let them focus on more rewarding work.
Cardinal, meanwhile, is a robotic work cell that sorts heavy packages of up to 50 pounds, during the shipping process. The company is testing a pilot of the system right now and expects to deploy into to its sorting facilities at some point next year.
Also demoed on the stage today was the Amazon Robotics Identification system. The device looks a bit like an airport scanner, allowing employees to quickly input packages using “natural movements.” The company notes, “AR ID removes the manual scanning process by using a unique camera system that runs at 120 frames per second, giving employees greater mobility and helping reduce the risk of injury.”
Lastly is another arm-based picking system. It’s effectively a large, mobile, shelf-based system that utilizes the arm to retrieve containers to hand to the human employee. The company notes, “Our new Containerized Storage System puts employees in a safer and more ergonomic position through a highly choreographed dance of robotics and software.”
What’s most interesting viewing these updates from a far is the integration Amazon has managed, across a range of different tasks. Of course, Amazon has the marked advantage of being able to develop its own systems for its own warehouse — that, along with its huge resources, are going to prove extremely difficult for smaller companies to keep up.
pound pandemic testingInternational
Repeated COVID-19 Vaccination Weakens Immune System: Study
Repeated COVID-19 Vaccination Weakens Immune System: Study
Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Repeated COVID-19…

Authored by Zachary Stieber via The Epoch Times (emphasis ours),
Repeated COVID-19 vaccination weakens the immune system, potentially making people susceptible to life-threatening conditions such as cancer, according to a new study.
Multiple doses of the Pfizer or Moderna COVID-19 vaccines lead to higher levels of antibodies called IgG4, which can provide a protective effect. But a growing body of evidence indicates that the “abnormally high levels” of the immunoglobulin subclass actually make the immune system more susceptible to the COVID-19 spike protein in the vaccines, researchers said in the paper.
They pointed to experiments performed on mice that found multiple boosters on top of the initial COVID-19 vaccination “significantly decreased” protection against both the Delta and Omicron virus variants and testing that found a spike in IgG4 levels after repeat Pfizer vaccination, suggesting immune exhaustion.
Studies have detected higher levels of IgG4 in people who died with COVID-19 when compared to those who recovered and linked the levels with another known determinant of COVID-19-related mortality, the researchers also noted.
A review of the literature also showed that vaccines against HIV, malaria, and pertussis also induce the production of IgG4.
“In sum, COVID-19 epidemiological studies cited in our work plus the failure of HIV, Malaria, and Pertussis vaccines constitute irrefutable evidence demonstrating that an increase in IgG4 levels impairs immune responses,” Alberto Rubio Casillas, a researcher with the biology laboratory at the University of Guadalajara in Mexico and one of the authors of the new paper, told The Epoch Times via email.
The paper was published by the journal Vaccines in May.
Pfizer and Moderna officials didn’t respond to requests for comment.
Both companies utilize messenger RNA (mRNA) technology in their vaccines.
Dr. Robert Malone, who helped invent the technology, said the paper illustrates why he’s been warning about the negative effects of repeated vaccination.
“I warned that more jabs can result in what’s called high zone tolerance, of which the switch to IgG4 is one of the mechanisms. And now we have data that clearly demonstrate that’s occurring in the case of this as well as some other vaccines,” Malone, who wasn’t involved with the study, told The Epoch Times.
“So it’s basically validating that this rush to administer and re-administer without having solid data to back those decisions was highly counterproductive and appears to have resulted in a cohort of people that are actually more susceptible to the disease.”
Possible Problems
The weakened immune systems brought about by repeated vaccination could lead to serious problems, including cancer, the researchers said.
Read more here...
Spread & Containment
Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked
Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked
Authored by Jack Phillips via The Epoch Times (emphasis ours),
Twitter…

Authored by Jack Phillips via The Epoch Times (emphasis ours),
Twitter owner Elon Musk invited Democrat presidential candidate Robert F. Kennedy Jr. for a discussion on his Twitter Spaces after Kennedy said his campaign was suspended by Meta-owned Instagram.
“Interesting… when we use our TeamKennedy email address to set up @instagram accounts we get an automatic 180-day ban. Can anyone guess why that’s happening?” he wrote on Twitter.
An accompanying image shows that Instagram said it “suspended” his “Team Kennedy” account and that there “are 180 days remaining to disagree” with the company’s decision.
In response to his post, Musk wrote: “Would you like to do a Spaces discussion with me next week?” Kennedy agreed, saying he would do it Monday at 2 p.m. ET.
Hours later, Kennedy wrote that Instagram “still hasn’t reinstated my account, which was banned years ago with more than 900k followers.” He argued that “to silence a major political candidate is profoundly undemocratic.”
“Social media is the modern equivalent of the town square,” the candidate, who is the nephew of former President John F. Kennedy, wrote. “How can democracy function if only some candidates have access to it?”
The Epoch Times approached Instagram for comment.
Interesting… when we use our TeamKennedy email address to set up @instagram accounts we get an automatic 180-day ban. Can anyone guess why that’s happening? pic.twitter.com/0G8oRnoXTv
— Robert F. Kennedy Jr (@RobertKennedyJr) June 2, 2023
It’s not the first time that either Facebook or Instagram has taken action against Kennedy. In 2021, Instagram banned him from posting claims about vaccine safety and COVID-19.
After he was banned by the platform, Kennedy said that his Instagram posts raised legitimate concerns about vaccines and were backed by research. His account was banned just days after Facebook and Instagram announced they would block the spread of what they described as misinformation about vaccines, including research saying the shots cause autism, are dangerous, or are ineffective.
“This kind of censorship is counterproductive if our objective is a safe and effective vaccine supply,” he said at the time.
Read more here...
International
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
Authored by Jessie Zhang via Thje Epoch…

Authored by Jessie Zhang via Thje Epoch Times (emphasis ours),
An Australian and Swedish investigation has found that among the hundreds of COVID-19 research papers that have been withdrawn, a retracted study linking the drug hydroxychloroquine to increased mortality was the most cited paper.
With 1,360 citations at the time of data extraction, researchers in the field were still referring to the paper “Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis” long after it was retracted.
Authors of the analysis involving the University of Wollongong, Linköping University, and Western Sydney Local Health District wrote (pdf) that “most researchers who cite retracted research do not identify that the paper is retracted, even when submitting long after the paper has been withdrawn.”
“This has serious implications for the reliability of published research and the academic literature, which need to be addressed,” they said.
“Retraction is the final safeguard against academic error and misconduct, and thus a cornerstone of the entire process of knowledge generation.”
Scientists Question Findings
Over 100 medical professionals wrote an open letter, raising ten major issues with the paper.
These included the fact that there was “no ethics review” and “unusually small reported variances in baseline variables, interventions and outcomes,” as well as “no mention of the countries or hospitals that contributed to the data source and no acknowledgments to their contributions.”

Other concerns were that the average daily doses of hydroxychloroquine were higher than the FDA-recommended amounts, which would present skewed results.
They also found that the data that was reportedly from Australian patients did not seem to match data from the Australian government.
Eventually, the study led the World Health Organization to temporarily suspend the trial of hydroxychloroquine on COVID-19 patients and to the UK regulatory body, MHRA, requesting the temporary pause of recruitment into all hydroxychloroquine trials in the UK.
France also changed its national recommendation of the drug in COVID-19 treatments and halted all trials.
Currently, a total of 337 research papers on COVID-19 have been retracted, according to Retraction Watch.
Further retractions are expected as the investigation of proceeds.
-
Spread & Containment5 hours ago
Robert F. Kennedy Jr. Banned By Major Social Media Site, Campaign Pages Blocked
-
International7 hours ago
Study Falsely Linking Hydroxychloroquine To Increased Deaths Frequently Cited Even After Retraction
-
Spread & Containment15 hours ago
Mark Zuckerberg Moves to Kill a Pandemic Habit
-
International15 hours ago
Complying, Not Defying: Twitter And The EU Censorship Code
-
Government11 hours ago
Biden Signs Debt Ceiling Bill, Ending Monthslong Political Battle
-
Uncategorized8 hours ago
Warren Buffett’s Advice on Stocks vs. Bonds
-
Spread & Containment12 hours ago
Mark Zuckerberg Makes a Bold Move
-
International4 hours ago
Repeated COVID-19 Vaccination Weakens Immune System: Study